Oncologica secures last available state of the art laboratory suite within the Newnham Building at Chesterford Research Park
Chesterford Research Park is delighted to confirm that Oncologica has secured the last available suite within the newly re-configured Newnham building at the Park and will take up occupancy with immediate effect post partial practical completion, which is due within...
Inventive use of space allows Diagnostics for the Real World to keep on top of demand for COVID-19 test kits
Chesterford Research Park based Diagnostics for the Real World (DRW) made worldwide headlines earlier this year with a game-changing way of testing for COVID-19. The University of Cambridge spinout responded quickly to the pandemic by adapting its HIV testing machine,...
Chesterford Research Park occupier Diagnostics for the Real World rapid COVID-19 test rolled out to NHS
New testing devices developed by a Cambridge team that can diagnose Covid-19 in less than 90 minutes are being used at Addenbrooke’s Hospital. The portable machines, called Samba II, have been developed by a University of Cambridge spin-off company...
Lonza latest pharma for Chesterford Research Park
Lonza signs 15-year lease of the 42,000 sq ft Gonville Building at Chesterford Research Park. The Swiss multinational CDMO, which provides contract development and manufacturing services to the pharmaceutical and biotech industries, has signed a 15-year lease of the...Isomerase scaling at Chesterford Research Park
Isomerase has secured the first pre-let within the Newnham Building at Chesterford Research Park. The move to Suite 4 of the new building on its completion in mid-2020 will facilitate planned future growth for the successful natural products discovery and development...
